supported by grants from the National Natural Science Foundation of China(No.81270255 to L-SW)
We aimed to investigate the effectiveness and safety of angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin Ⅱ receptor blockers (ARBs) on preventing atrial fibrillation in essential hypertensive patie...
Objective The purpose of this review was to delineate our current knowledge of the close relationship between the abundance of epicardial adipose tissue (EAT) and the risk of all major cardiovascular disease, especi...
Background Many recipients of implantable cardiac electronic devices have atrial fibrillation (AF) occurrences after device implantation, even if there is no previous history of AF, and some of the episodes are asym...
Atrial fibrillation (AF) is the most frequent arrhythmia .whose incidence increases with age. At presentabout 1%-2% of the European population suffer from AF. Presumably about 25% of the population between 40 and 50...
Atrial fibrillation (AF) is one of the most common .arrhythmias in clinical practice. AF results in electrophysiological alterations which involve increased atrial effective refractory period and atrial effective re...